Janux Therapeutics Announces First Patient Dosed with JANX008 in First-in-Human Phase 1 Clinical Trial in Patients with Solid Tumors

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applyin...

April 21, 2023 | Friday | News
Roquette unveils its $25 million Pharmaceutical Innovation Center in the United States.

Roquette, a global leader  in plant-based ingredients and a leading provider of pharmaceutical and nutraceutical  excipients, today celebrates th...

April 20, 2023 | Thursday | News
Study: Drug May Delay Earliest Symptoms of Multiple Sclerosis

The preliminary study, released April 19, 2023, will be presented at the American Academy of Neurology's 75th Annual Meeting, being held in person in Bosto...

April 20, 2023 | Thursday | News
JACS Solutions and Baicells to Unveil End-to-End Private 5G Solutions for the Healthcare Industry

Baicells Technologies, a global provider of LTE and 5G network solutions, and JACS Solutions, a global provider of custom connectivity solutions for indust...

April 20, 2023 | Thursday | News
PANTHERx® Rare Announces Release of CUVRIOR™ to Treat Wilson Disease

"We are pleased to add CUVRIOR to the list of PANTHERx® medications. The PANTHERx team works hard to make a positive difference in the lives of ou...

April 20, 2023 | Thursday | News
Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Announced an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) (NCT045...

April 19, 2023 | Wednesday | News
Cali Biosciences Begins Phase III Study of Long-Acting Ropivacaine for Pain Reduction After Surgery

Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali" or "Cali Biosciences"), a biopharmaceutical company focused on the research and development o...

April 19, 2023 | Wednesday | News
Nona Biosciences & Washington University Partner to Combat RNA Viruses

"This collaboration represents an exciting opportunity for Nona Biosciences to leverage its fully human antibody H2L2 transgenic mice, together with the te...

April 19, 2023 | Wednesday | News
Xyall and Indica Labs collaborate to transform precision oncology workflows

Bridging the gap between histopathology and molecular pathology Xyall and Indica Labs have entered into a global strategic partnership designed to bridge ...

April 18, 2023 | Tuesday | News
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol

As disclosed in September 2022, Avenue received meeting minutes from the FDA regarding a Type A meeting conducted on August 9, 2022, for IV Tramadol. At th...

April 18, 2023 | Tuesday | News
Experience Asia's Leading Biotech Event: BIO Asia-Taiwan 2023

Asia’s largest bioindustry-focused gathering, BIO Asia–Taiwan 2023, will be held July 26th to 30th, 2023, in Taipei, Taiwan. Co-organized by BI...

April 18, 2023 | Tuesday | News
Agena Bioscience and nRichDX Partner for Liquid Biopsy Analyte Extraction and Detection Solutions

Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researcher...

April 17, 2023 | Monday | News
Atmo Biosciences strengthens U.S. focus with new board appointment and establishment of San Diego office

The increased presence in the U.S. comes as Atmo Biosciences prepares to begin a multi-site pivotal study to support a U.S. Food and Drug Administration (F...

April 17, 2023 | Monday | News
Imprivata Launches Healthcare Digital Identity Maturity Model and Assessment

Imprivata, the digital identity company for life-and mission-critical industries,  announced the launch of the Imprivata Digital Identity Maturity Mod...

April 17, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close